NCMAG122 Pembrolizumab Advice Document
Posted on:
Document Type
NCMAG advice
Process guidance
Summary
Pembrolizumab for the neoadjuvant treatment of stage IIIB to IIID or oligometastatic resectable stage IV melanoma
Decision: Supported